Nuwellis Inc (NUWE)

$1.03 +0.02 (1.98%)
Market Cap 2.40M
Revenue (ttm) 8.27M
Net Income (ttm) -17.52M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -211.85%
Debt to Equity Ratio 0.00
Volume 148,100
Avg Vol 2,617,884
Day's Range N/A - N/A
Shares Out 2.31M
Stochastic %K 14%
Beta -0.03
Analysts Hold
Price Target $11.00

Company Profile

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and...

Industry: Medical Devices
Sector: Healthcare
Phone: 952 345 4200
Address:
12988 Valley View Road, Eden Prairie, United States
done84
done84 Mar. 20 at 7:03 PM
$NUWE .98 to go. Worth absolutely nothing..I hope the whole management team will rot in hell! F*ckers! 🖕🖕🖕
0 · Reply
Dominicstocks
Dominicstocks Mar. 20 at 6:45 PM
$NUWE You’re crazy until you’re successful Once you’re successful you’re a genius 
0 · Reply
done84
done84 Mar. 19 at 6:21 PM
$NUWE Scam of the Wall Street! 🖕🖕
0 · Reply
bazooka007
bazooka007 Mar. 19 at 6:57 AM
$NUWE Saubande!
0 · Reply
ManuelFromGermany
ManuelFromGermany Mar. 18 at 7:31 PM
$NUWE Sauerrei was hier passiert!
0 · Reply
done84
done84 Mar. 18 at 4:32 PM
$NUWE this sh*t has nothing to do here. Let's go to .10 and R/S again.. need a big one to feed the shorts further just like in the last 15 years. Scam! 🖕🖕
0 · Reply
done84
done84 Mar. 17 at 6:19 PM
$NUWE scam...fraud..toxic dilution machine. Rot in hell nuwellis! 🖕🖕🖕
0 · Reply
Vaderesking
Vaderesking Mar. 17 at 12:44 PM
We post everyday, it’s free, we do not sell anything, we do it to better our skillset. Keep us accountable. $SPY Not saying we told you so, but that move yesterday was almost scripted! I hope folks took the scalp calls, okay for today, we are at a critical junction here, market is testing this 671.01 zone, absolutely needs over it. Anything under 668 would signal momentum loss here on the weekly. $NQ watch 24887, that’s our critical support indicator on the daily $QQQ 600.5 easy entry here. That’s our stop loss for those who have weeklies. $RTY I’ll be honest, not the strength I expected here. 2500 level key, money flowing out of small caps again? Let’s see $NUWE on my list this morning over 1.33
0 · Reply
alfredchchspain
alfredchchspain Mar. 17 at 9:16 AM
$NUWE THE LAST FOOL👇
1 · Reply
bazooka007
bazooka007 Mar. 16 at 6:38 PM
$NUWE the rats coming out of their holes. You know what to do. rule #1 kaufen wenn die kanonen donnern. Noch fragen?
0 · Reply
Latest News on NUWE
Nuwellis Completes Acquisition of Rendiatech

Mar 17, 2026, 8:00 AM EDT - 4 days ago

Nuwellis Completes Acquisition of Rendiatech

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

Mar 10, 2026, 8:15 AM EDT - 11 days ago

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy

Mar 5, 2026, 8:00 AM EST - 16 days ago

Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy

Nuwellis Appoints David A. McDonald and Martin J.

Feb 26, 2026, 8:00 AM EST - 23 days ago

Nuwellis Appoints David A. McDonald and Martin J.

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026

Feb 24, 2026, 8:00 AM EST - 25 days ago

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026

Nuwellis Appoints Carisa Schultz as Chief Financial Officer

Jan 30, 2026, 8:00 AM EST - 7 weeks ago

Nuwellis Appoints Carisa Schultz as Chief Financial Officer

Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market

Jan 29, 2026, 4:36 PM EST - 7 weeks ago

Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market

Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy

Jan 29, 2026, 4:35 PM EST - 7 weeks ago

Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy

Nuwellis Stock Surges 100% As $2 Microcap Beats Big Pharma In Infant Healthcare

Jan 27, 2026, 11:14 AM EST - 7 weeks ago

Nuwellis Stock Surges 100% As $2 Microcap Beats Big Pharma In Infant Healthcare

Nuwellis Announces Changes to Board of Directors

Jan 23, 2026, 4:40 PM EST - 2 months ago

Nuwellis Announces Changes to Board of Directors

Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy

Jan 6, 2026, 8:15 AM EST - 2 months ago

Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy

Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings

Dec 9, 2025, 8:15 AM EST - 3 months ago

Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings

Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.

Dec 4, 2025, 8:15 AM EST - 3 months ago

Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum

Nov 12, 2025, 8:15 AM EST - 4 months ago

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum

Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology

Nov 10, 2025, 9:00 AM EST - 4 months ago

Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology

Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

Oct 23, 2025, 9:00 AM EDT - 5 months ago

Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

Sep 30, 2025, 8:45 AM EDT - 6 months ago

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration

Sep 18, 2025, 9:00 AM EDT - 6 months ago

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration

Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment

Sep 17, 2025, 10:16 AM EDT - 6 months ago

Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment

Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Sep 9, 2025, 9:00 AM EDT - 6 months ago

Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

Sep 4, 2025, 8:15 AM EDT - 7 months ago

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

Aug 21, 2025, 8:15 AM EDT - 7 months ago

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

Aug 19, 2025, 8:15 AM EDT - 7 months ago

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Aug 15, 2025, 8:15 AM EDT - 7 months ago

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

Aug 14, 2025, 8:15 AM EDT - 7 months ago

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

Aug 7, 2025, 8:15 AM EDT - 8 months ago

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

Aug 6, 2025, 8:15 AM EDT - 8 months ago

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

Aug 5, 2025, 8:15 AM EDT - 8 months ago

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

Nuwellis Stockholders Approve All Proposals at Special Meeting

Aug 4, 2025, 5:24 PM EDT - 8 months ago

Nuwellis Stockholders Approve All Proposals at Special Meeting

Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Jul 23, 2025, 8:45 AM EDT - 8 months ago

Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Jul 23, 2025, 8:15 AM EDT - 8 months ago

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

Jul 22, 2025, 8:15 AM EDT - 8 months ago

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

Jul 17, 2025, 7:35 AM EDT - 8 months ago

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation

Jul 15, 2025, 4:05 PM EDT - 8 months ago

Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation

Nuwellis Appoints John Erb as Chief Executive Officer

Jul 2, 2025, 8:15 AM EDT - 9 months ago

Nuwellis Appoints John Erb as Chief Executive Officer

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

Jun 10, 2025, 4:15 PM EDT - 10 months ago

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

Jun 9, 2025, 9:15 AM EDT - 10 months ago

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

May 13, 2025, 7:00 AM EDT - 11 months ago

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

May 12, 2025, 7:00 AM EDT - 11 months ago

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

May 8, 2025, 7:00 AM EDT - 11 months ago

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

Apr 24, 2025, 7:00 AM EDT - 11 months ago

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

Apr 22, 2025, 4:05 PM EDT - 11 months ago

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results

Mar 11, 2025, 8:00 AM EDT - 1 year ago

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results

Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO

Feb 24, 2025, 4:05 PM EST - 1 year ago

Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO

JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis

Feb 20, 2025, 8:00 AM EST - 1 year ago

JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

Feb 18, 2025, 4:15 PM EST - 1 year ago

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

Nov 11, 2024, 8:00 AM EST - 1 year ago

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

Nov 5, 2024, 9:28 AM EST - 1 year ago

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

Nov 4, 2024, 8:30 AM EST - 1 year ago

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

Nuwellis Announces Preliminary Results for Third Quarter of 2024

Nov 1, 2024, 4:15 PM EDT - 1 year ago

Nuwellis Announces Preliminary Results for Third Quarter of 2024

done84
done84 Mar. 20 at 7:03 PM
$NUWE .98 to go. Worth absolutely nothing..I hope the whole management team will rot in hell! F*ckers! 🖕🖕🖕
0 · Reply
Dominicstocks
Dominicstocks Mar. 20 at 6:45 PM
$NUWE You’re crazy until you’re successful Once you’re successful you’re a genius 
0 · Reply
done84
done84 Mar. 19 at 6:21 PM
$NUWE Scam of the Wall Street! 🖕🖕
0 · Reply
bazooka007
bazooka007 Mar. 19 at 6:57 AM
$NUWE Saubande!
0 · Reply
ManuelFromGermany
ManuelFromGermany Mar. 18 at 7:31 PM
$NUWE Sauerrei was hier passiert!
0 · Reply
done84
done84 Mar. 18 at 4:32 PM
$NUWE this sh*t has nothing to do here. Let's go to .10 and R/S again.. need a big one to feed the shorts further just like in the last 15 years. Scam! 🖕🖕
0 · Reply
done84
done84 Mar. 17 at 6:19 PM
$NUWE scam...fraud..toxic dilution machine. Rot in hell nuwellis! 🖕🖕🖕
0 · Reply
Vaderesking
Vaderesking Mar. 17 at 12:44 PM
We post everyday, it’s free, we do not sell anything, we do it to better our skillset. Keep us accountable. $SPY Not saying we told you so, but that move yesterday was almost scripted! I hope folks took the scalp calls, okay for today, we are at a critical junction here, market is testing this 671.01 zone, absolutely needs over it. Anything under 668 would signal momentum loss here on the weekly. $NQ watch 24887, that’s our critical support indicator on the daily $QQQ 600.5 easy entry here. That’s our stop loss for those who have weeklies. $RTY I’ll be honest, not the strength I expected here. 2500 level key, money flowing out of small caps again? Let’s see $NUWE on my list this morning over 1.33
0 · Reply
alfredchchspain
alfredchchspain Mar. 17 at 9:16 AM
$NUWE THE LAST FOOL👇
1 · Reply
bazooka007
bazooka007 Mar. 16 at 6:38 PM
$NUWE the rats coming out of their holes. You know what to do. rule #1 kaufen wenn die kanonen donnern. Noch fragen?
0 · Reply
Dominicstocks
Dominicstocks Mar. 16 at 5:37 PM
$NUWE
0 · Reply
HNA126
HNA126 Mar. 16 at 4:53 PM
$NUWE 💩 not worth even $0.01 scam
0 · Reply
done84
done84 Mar. 16 at 4:52 PM
$NUWE nothing changed. Business as usual..scam company! F*ck you CHFS or NUWE or whatever you POS..including the complete "management"!🖕🖕🖕
0 · Reply
alfredchchspain
alfredchchspain Mar. 16 at 11:32 AM
$NUWE SCAM-99% EVERY YEAR
1 · Reply
CashDrifter
CashDrifter Mar. 13 at 5:38 AM
$NUWE On March 5, 2026, the company appointed Dr. Stuart L. Goldstein as Director of Clinical Strategy. He is a prominent expert in pediatric nephrology. $VEEE Management cut operating expenses by approximately 27% and reduced field inventory significantly (from 140 units to 52)
0 · Reply
done84
done84 Mar. 12 at 5:54 PM
$NUWE 👇🤡
0 · Reply
bazooka007
bazooka007 Mar. 12 at 4:10 PM
$NUWE shorties are warning to buy this @ 1,30. Exactly my kind of humour.
0 · Reply
Bryan1111
Bryan1111 Mar. 12 at 3:36 PM
$NUWE out of cash . definitely dillute . be careful guys
1 · Reply
Bryan1111
Bryan1111 Mar. 11 at 8:12 PM
$NUWE Revenue increased by 208% and they still managed to save $3 million.
1 · Reply
Bryan1111
Bryan1111 Mar. 11 at 7:55 PM
$NUWE 208% ??
0 · Reply
baa75
baa75 Mar. 11 at 7:12 PM
$NUWE 🧐
0 · Reply
done84
done84 Mar. 10 at 1:49 PM
$NUWE yep, out of cash (again). It's time to dillute the hell out of it a drop the R/S bomb (again). Neverending toxic games and money theft. Business as usual..pure scam. Nothing else. 🖕🖕
0 · Reply